Stockscreener 앱 받기
4.19
0.48%
0.02
시간 외 거래:
4.23
0.04
+0.95%
전일 마감가:
$4.17
열려 있는:
$4.17
하루 거래량:
37,158
Relative Volume:
0.02
시가총액:
$22.53M
수익:
$15.66M
순이익/손실:
$5.83M
주가수익비율:
-0.1754
EPS:
-23.8939
순현금흐름:
$466.20K
1주 성능:
+1.95%
1개월 성능:
+11.14%
6개월 성능:
-48.90%
1년 성능:
+20.06%
1일 변동 폭
$4.124
$4.25
1주일 범위
$3.98
$4.25
52주 변동 폭
$3.4178
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
명칭
Neuphoria Therapeutics Inc
전화
781-439-5551
주소
100 SUMMIT DR, BURLINGTON
NEUP을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
4.19 | 22.42M | 15.66M | 5.83M | 466.20K | -23.89 |
|
VRTX
Vertex Pharmaceuticals Inc
|
468.41 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
753.55 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
814.74 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
357.98 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.32 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-09-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | 재확인 | Maxim Group | Buy |
| 2022-01-10 | 개시 | Berenberg | Buy |
| 2022-01-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2022-01-10 | 개시 | Evercore ISI | Outperform |
| 2022-01-10 | 개시 | H.C. Wainwright | Buy |
모두보기
Neuphoria Therapeutics Inc 주식(NEUP)의 최신 뉴스
Can Neuphoria Therapeutics Inc. outperform in the next rallyMarket Sentiment Summary & Entry Point Confirmation Alerts - mfd.ru
Wall Street Recap: Whats the outlook for Neuphoria Therapeutics Incs sectorPortfolio Gains Report & Weekly Hot Stock Watchlists - baoquankhu1.vn
Exit Recap: What is the implied volatility of Lakeland Financial CorporationMarket Trend Report & Weekly Chart Analysis and Guides - baoquankhu1.vn
Neuphoria receives $15M milestone payment from Merck - MSN
Market Wrap: Will Neuphoria Therapeutics Inc outperform during market ralliesEarnings Risk Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Will Neuphoria Therapeutics Inc stock outperform value stocksStock Surge & Stepwise Entry/Exit Trade Alerts - Bộ Nội Vụ
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Neuphoria Shares Climb 4% After Launching Strategic Review to Enhance Shareholder Value - MSN
Why Neuphoria Therapeutics Inc. stock could outperform in 2025Inflation Watch & Stock Timing and Entry Methods - ulpravda.ru
Neuphoria Therapeutics Inc.Common Stock (NQ: NEUP - FinancialContent
Ford, Intel, AMD, Neuphoria Therapeutics, Deckers Outdoor: Stocks Making The Biggest Moves Today - MSN
Will Neuphoria Therapeutics Inc. stock outperform Dow Jones indexBreathability and Upper Notes & lightweight options for faster days - Улправда
Neuphoria Therapeutics Announces CEO Transition and Consulting Role - The Globe and Mail
How strong is Neuphoria Therapeutics Inc. stock balance sheetMarket Trend Summary & High Accuracy Swing Entry Alerts - ulpravda.ru
What risks investors should watch in Neuphoria Therapeutics Inc. stock2025 Biggest Moves & Entry Point Strategy Guides - Улправда
Will Neuphoria Therapeutics Inc. stock see insider buyingMarket Trend Report & Stock Timing and Entry Methods - ulpravda.ru
Does Neuphoria Therapeutics Inc. stock trade at a discount to peers2025 Investor Takeaways & Weekly Watchlist for Consistent Profits - ulpravda.ru
Can Neuphoria Therapeutics Inc. stock double in next 5 years2025 Valuation Update & Weekly High Potential Stock Alerts - Улправда
Will Neuphoria Therapeutics Inc. stock split again soon2025 Trading Volume Trends & Weekly Hot Stock Watchlists - Улправда
Growth Recap: How Neuphoria Therapeutics Inc. stock reacts to oil pricesTrade Analysis Summary & Proven Capital Preservation Methods - Улправда
How Neuphoria Therapeutics Inc. stock reacts to oil prices2025 Momentum Check & AI Forecasted Entry/Exit Points - Улправда
How Neuphoria Therapeutics Inc. stock benefits from tech adoptionWall Street Watch & Precise Swing Trade Alerts - Улправда
Setup Watch: How strong is Neuphoria Therapeutics Inc. stock balance sheet2025 Key Lessons & Real-Time Buy Signal Notifications - Улправда
Is Neuphoria Therapeutics Inc. stock trading near support levels2025 Analyst Calls & Verified Trade Idea Suggestions - ulpravda.ru
Neuphoria Therapeutics Inc. Announces Termination of Spyridon Papapetropoulos as CEO and Appointment as Interim CEO Effective December 31, 2025 - marketscreener.com
Published on: 2026-01-07 22:57:50 - Улправда
Is Neuphoria Therapeutics Inc. stock a safe investment in uncertain markets2026 world cup usa national team quarterfinals defensive leaders high defensive line group prediction insights - ulpravda.ru
2026 world cup team news comparison: How buybacks impact Neuphoria Therapeutics Inc. stock value2026 world cup usa national team round of 32 goalkeepers low block defense match prediction expert opinion - ulpravda.ru
Neuphoria Therapeutics to receive $15M milestone payment from Merck - MSN
Aug Intraday: Will Neuphoria Therapeutics Inc stock outperform Dow Jones indexShare Buyback & Low Risk Growth Stock Ideas - moha.gov.vn
Weekly Recap: Why Neuphoria Therapeutics Inc. stock could outperform in 2025Insider Buying & Free Fast Entry Momentum Trade Alerts - ulpravda.ru
Published on: 2025-12-20 15:41:19 - Улправда
Why Neuphoria Therapeutics Inc. stock remains on watchlistsIPO Watch & Weekly Return Optimization Alerts - Улправда
Will Neuphoria Therapeutics Inc. stock remain a Wall Street favoriteJuly 2025 Chart Watch & Daily Entry Point Alerts - DonanımHaber
How Neuphoria Therapeutics Inc. stock reacts to global recession fears2025 Volume Leaders & AI Optimized Trade Strategies - Улправда
Is Neuphoria Therapeutics Inc. stock positioned for digital transformationWeekly Risk Summary & Weekly Stock Breakout Alerts - DonanımHaber
How Neuphoria Therapeutics Inc. stock benefits from global expansionJuly 2025 Drop Watch & Accurate Buy Signal Notifications - DonanımHaber
Neuphoria Therapeutics (NEUP) details 2025 annual meeting and vote outcomes - Stock Titan
Neuphoria Therapeutics Inc (NEUP) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.92%
2.36%
자본화:
|
볼륨(24시간):